Efficacy of iron sulfate with ascorbic acid in pregnant women with iron deficiency of varying degrees of severity

Iron deficiency anemia (IDA) is one of the most common diseases in the world, characterized by hemoglobin synthesis disorder due to iron deficiency and manifested by anemia. According to WHO, the rate of IDA in pregnant women in different countries ranges from 21 to 80%, judging by the level of hemoglobin, and from 49 to 99% - by serum iron. Lack of treatment of iron-deficient pregnant women with varying degrees of iron deficiency leads to an increase in the frequency of complicated pregnancy, such as the threat of termination of pregnancy, placental insufficiency, delay in intrauterine development and hypoxia of the fetus, premature delivery, poor uterine contraction strength, pathological bleeding, infectious complications. Aim of the study: study of the efficacy of the drug containing iron sulfate (Ferrous sulfate) and ascorbic acid in pregnant women with latent and manifest forms of iron deficiency. Patients and methods: 66 pregnant women were examined. Group 1 consisted of 36 pregnant women with latent iron deficiency, Group 2–30 pregnant women with manifest iron deficiency and moderate anemia. Pregnant women in the 1st group were prescribed the drug only for 1 month due to the fact that there were no manifestations of anemia in this category of patients. Blood parameters were monitored dynamically after 1 month of treatment and after 2 months, which means after 1 month of absence of the drug intake. Patients of the 2nd group received treatment during 2 months, dynamic treatment after laboratory parameters was carried out after 1 and 2 months of treatment. Results of the study. Analyzing the data obtained, it was found that all laboratory parameters differ significantly from those before treatment. Pregnant women of the 1st group have no reliable changes between the parameters after 1 and 2 months of observations, as during this period the patients did not receive iron medication. And even a slight decrease in some indicators is noted, but when compared with laboratory data before treatment, the results differ significantly. Conclusion: Ferrous sulfate and ascorbic acid can be recommended to compensate iron deficiency in pregnant women with LID to prevent the development of anemia, in patients with MID to treat anemia and prevent the development of possible complications in pregnant women associated with this condition. Thus, earlier detection and elimination of LID leads to prevention of anemia later on.

iron deficiency, anemia in pregnant women, serum iron, ferritin, transferrin, iron medications, sorbifer, pregnancy

1. Доброхотова Ю.Э., Бахарева И.В. Железодефицитная анемия беременных: профилактика и лечение. РМЖ. 2018;26(2-1):59-64. [Dobrokhotova Yu. E., Bakhareva I. V. Iron deficiency anemia of pregnant women: prevention and treatment. RMJ.2018;26(2-1): 59- 64.] (In Russ.)

2. Friedrisch J.R., Friedrisch B.K. Prophylactic Iron Supplementation in Pregnancy: A Controversial Issue. Biochem Insights. 2017;27:10 doi: 10.1177/1178626417737738.

3. Протопопова Т.А. Железодефицитная анемия и беременность. РМЖ. Мать и дитя. 2012;20(17):862-866. [Protopopova T.A. Iron deficiency anemia and pregnancy. RMJ. Mother and child [RMJ. Mat’ i ditya]. 2012;20(17): 862-866.] (In Russ.)

4. Федеральные клинические рекомендации. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. РОАГ. ФГБУ «Научный центр акушерства, гинекологии и перинатологии им. В. И. Кулакова» Минздрава России. 2013:26. [Federal clinical guidelines. Diagnostics, prevention and treatment of iron deficiency in pregnant women and mothers in childbirth. FSBU «Scientific Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov» of the Ministry of Health of the Russian Federation. 2013:26.] (In Russ.)

5. Клинические рекомендации. Кровесберегающие технологии в акушерской практике. 2014:31. [Clinical recommendations. Bloodsaving technologies in obstetric practice. 2014:31.] (In Russ.)

6. Badfar G., Shohani M., Soleymani A., Azami M. Maternal anemia during pregnancy and small for gestational age: A systematic review and meta-analysis. J Matern Fetal Neonatal Med.2017;1:131. doi: 10.1080/14767058.2017.1411477.

7. Bencaiova G., Burkhardt T., Breymann C. Anemia -prevalence and risk factors in pregnancy. Eur. J. Intern. Med.2012;23(6):529-533.

8. Крючкова А.В., Пятницина С.И., Кондусова Ю.В. Железодефицитная анемия и беременность (сравнительная эффективность лечения ЖДА у беременных различными препаратами железа). Вестник Ивановской медицинской академии. 2011;5(16):43-44. [Kryuchkova A.V., Pyatnitsina S.I., Kondusova Yu. V. Irondeficiency anemia and pregnancy (comparative effectiveness of treatment of IDA in pregnant women with different iron medications). Bulletin of the Ivanovo Medical Academy [Vestnik Ivanovskoj medicinskoj akademii]. 2011;5(16):43-44.] (In Russ.)

9. Самсыгина Г.А. Железодефицитная анемия у беременных женщин и детей. Педиатрия. 2014;3:34-37. [Samsygina G.A. Iron deficiency anemia in pregnant women and children. Pediatrics [Pediatriya]. 2014;3:34-37.] (In Russ.)

10. Beucher G., Grossetti E., Simonet T. et al. Iron deficiency anemia and pregnancy Prevention and treatment. J. Gynecol. Obstet. Biol. Reprod. 2011;40(3):185–200.

11. Khalafallah A.A., Dennis A.E. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy. J. Pregnancy. 2012;630:519.

12. Стуклов Н.И., Луговая Е.О., Леваков С.А. Новые возможности прогнозирования и оценки эффективности лечения железодефицитной анемии. Фарматека. 2010;9:72-76. [Stuklov N.I., Lugovaya E.O., Levakov S.A. New possibilities for prognostication and evaluation of the effectiveness of iron-deficiency anemia treatment. Pharmacy [Farmateka].2010;9:72-76.] (In Russ.)

13. Левашова О.В., Коломиец Д.И. Структура назначения железосодержащих препаратов беременным женщинам при железодефицитной анемии в условиях типичной амбулаторной практики. Материалы международной конференции: Современные стратегии и технологии профилактики, диагностики, лечения и реабилитации больных разного возраста, страдающих хроническими неинфекционными заболеваниями. 2018:167-172. [Levashova O.V., Kolomiets D.I. Structure of prescribing iron-containing drugs for pregnant women in case of iron-deficiency anemia in typical outpatient practice. Materials of the international conference: Modern strategies and technologies of prevention, diagnostics, treatment and rehabilitation of patients of different ages suffering from chronic noninfectious diseases. 2018:167-172.] (In Russ.)